Planta Med 2004; 70(12): 1230-1233
DOI: 10.1055/s-2004-835857
Letter
© Georg Thieme Verlag KG Stuttgart · New York

Activation of α1A-Adrenoceptor by Andrographolide to Increase Glucose Uptake in Cultured Myoblast C2C12 Cells

Jen-Hao Hsu1 , Shorong-Shii Liou2 , Bu-Chin Yu3 , Juei-Tang Cheng3 , Yang-Chang Wu1
  • 1Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung City, Taiwan
  • 2Department of Pharmacy, Tajen Institute of Technology, Yen-Pou, Ping Tung Shien, Taiwan
  • 3Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan City, Taiwan
Further Information

Publication History

Received: March 15, 2004

Accepted: August 19, 2004

Publication Date:
10 January 2005 (online)

Abstract

We investigated the mechanism of the plasma glucose lowering action of andrographolide, using radioactive glucose uptake into cultured myoblast C2C12 cells as the indicator. In C2C12 cells, andrographolide increased the radioactive glucose uptake in a concentration-dependent manner that was abolished by pretreatment with prazosin. Activation of α1-adrenoceptors by andrographolide was further indicated by the displacement of the [3 H]prazosin binding in C2C12 cells. The α1A-adrenoceptor appears to have caused the displacement, because RS17053 abolished this andrographolide-stimulated glucose uptake at concentrations sufficient to block the α1A-adrenoceptor. Inhibition of phospholipase C (PLC) with U73312 concentration-dependently decreased under the action of andrographolide in C2C12 cells. This inhibition of glucose uptake by U73122 was specific because the inactive congener, U73343, failed to influence the action of andrographolide. Moreover, both chelerythrine and GF 109203X diminished the action of andrographolide at concentrations sufficient to inhibit protein kinase C (PKC). Our data suggest that an activation of α1A-AR by andrographolide in C2C12 cells may increase the glucose uptake via the PLC-PKC pathway.

References

  • 1 Trivedi N P, Rawal U M. Hepatoprotective and antioxidant property of Andrographis paniculata (Nees) in BHC induced liver damage in mice.  Indian J Exp Biol. 2001;  39 41-6
  • 2 Panossian A, Hovhannisyan A, Mamikonyan G, Abrahamian H, Hambardzumyan E, Gabrielian E, Goukasova G, Wikman G, Wagner H. Pharmacokinetic and oral bioavailability of andrographolide from Andrographis paniculata fixed combination Kan Jang in rats and human.  Phytomedicine. 2000;  7 351-64
  • 3 Zhang X F, Tan B K. Antihyperglycaemic and anti-oxidant properties of Andrographis paniculata in normal and diabetic rats.  Clin Exp Pharmacol Physiol. 2000;  27 358-63
  • 4 Shen Y C, Chen C F, Chiou W F. Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) involved in its anti-inflammatory effect.  Br J Pharmacol. 2002;  135 399-406
  • 5 Yu B C, Hung C R, Chen W C, Cheng J T. Antihyperglycemic effect of andrographolide in streptozotocin-induced diabetic rats.  Planta Medica. 2003;  69 075-9
  • 6 Faintrenie G, Géloén A J. Alpha-1 adrenergic stimulation of glucose uptake in rat white adipocytes.  Pharmacol Exp Ther. 1998;  286 607-10
  • 7 Hieble J P, Bylund D B, Clarke D E, Eikenburg D C, Langer S Z, Lefkowitz R J, Minneman K P, Ruffolo RR J r. International Union of Pharmacology. X. Recommendation for nomenclature of alpha-1 adrenoceptors: consensus update.  Pharmacol Rev. 1995;  47 267-70
  • 8 Cheng J T, Liu I M. Stimulatory effect of caffeic acid on α1A-adrenoceptors to increase glucose uptake into cultured C2C12 cells.  Naunyn-Schmiedebergs Arch Pharmacol. 2000;  362 122-7
  • 9 Liu I M, Tsai C C, Lai T Y, Cheng J T. Stimulatory effect of isoferulic acid on alpha1A-adrenoceptor to increase glucose uptake into cultured myoblast C2C12 cell of mice.  Auton Neurosci. 2001;  88 175-80
  • 10 Marshall I, Burt R P, Green G M, Hussain M B, Chapple C R. Different subtypes of alpha 1A-adrenoceptor mediating contraction of rat epididymal vas deferens, rat hepatic portal vein and human prostate distinguished by the antagonist RS 17 053.  Br J Pharmacol. 1996;  119 407-15
  • 11 Liu I M, Huang L W, Cheng J T. Gene expression of α1A-adrenoceptor but not α1B-adrenoceptor in cultured C2C12 cells.  Neurosci Lett. 2000;  294 93-6
  • 12 Piascik M T, Guarino R D, Smith M S, Soltis E E, Saussy DL J r, Perez D M. The specific contribution of the novel alpha-1D adrenoceptor to the contraction of vascular smooth muscle.  J Pharmacol Exp Ther. 1995;  275 1583-9
  • 13 Smallridge R C, Kiang J G, Gist I D, Fein H G, Gallowat R J. U-73 122, an aminosteroid phospholipase C antagonist, noncompetitively inhibits thyrotropin-releasing hormone effects in GH3 rat pituitary cell.  Endocrinology. 1992;  131 1883-8
  • 14 Herbert J M, Augereau J M, Gleye J, Maffrand J P. Chelerythrine is a potent and specific inhibitor of protein kinase C.  Biochem Biophys Res Commun. 1990;  172 993-9
  • 15 Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M. et al . The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.  J Biol Chem. 1991;  266 15 771-81

Professor Yang-Chang Wu

Graduate Institute of Natural Products

Kaohsiung Medical University

Kaohsiung 807

Taiwan

Phone: +886-7-3121101, ext. 2197

Fax: +886-7-3114773

Email: yachwu@kmu. edu.tw

    >